Schedule 13G ownership disclosure

PDL BIOPHARMA INC

Security class unavailable · CUSIP: 69329Y104

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,089,742
Percent of class
5.4700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000072971-15-000428
Form type
SC 13G
Filer
PDL BIOPHARMA, INC.
CIK
CIK 882104
Filed
Feb 17, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub